Plain-English translation of NCT07006064 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new device called the SuperNO₂VA nasal mask during heart valve replacement procedures in older patients who receive sedation. The new mask is designed to deliver oxygen while also measuring carbon dioxide levels in exhaled breath, which helps doctors detect breathing problems earlier. Researchers want to see if this improved monitoring and oxygen delivery reduces dangerously low oxygen levels during the procedure compared to standard oxygen masks.
When patients receive sedation, their breathing can become shallow or stop temporarily, which can cause oxygen levels to drop dangerously. Current oxygen masks don't always catch these problems quickly enough. The new mask aims to solve this by providing better monitoring and support, which could make the procedure safer for older patients.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the new SuperNO₂VA mask or the standard oxygen mask during your scheduled heart valve procedure. The mask will be placed on your nose before sedation begins and will remain in place throughout the procedure. Doctors will monitor your oxygen and carbon dioxide levels as usual, and your care will proceed as planned—the only difference is which type of oxygen mask you receive.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Turkey (Türkiye)